» Articles » PMID: 21176078

The Role of a Leaky Epithelium and Potassium in the Generation of Bladder Symptoms in Interstitial Cystitis/overactive Bladder, Urethral Syndrome, Prostatitis and Gynaecological Chronic Pelvic Pain

Overview
Journal BJU Int
Specialty Urology
Date 2010 Dec 24
PMID 21176078
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The traditional diagnosis of interstitial cystitis (IC) only recognizes the severe form of the disease. The far more common early and intermittent phases of the disease are not perceived to be part of IC but rather are misdiagnosed as urinary tract infection, urethral syndrome, overactive bladder, chronic prostatitis, urethritis, or a type of gynecologic pelvic pain (such as endometriosis, vulvodynia, or some type of vaginitis). All of these patient groups actually suffer from the same bladder disease. This disease results from a leaky bladder epithelium and subsequent potassium leakage into the bladder interstitium that generates the symptoms of frequency, urgency, pain or incontinence in any combination. Robust scientific data now support this important concept. These data will be reviewed herein. The conclusions derived from these data substantially alter the paradigms for urology and gynecology in the generation of frequency, urgency and pelvic pain. All the above-mentioned syndromes unite into one primary disease process, lower urinary dysfunction epithelium, or LUDE disease, and not the 10 plus syndromes traditionally recognized.

Citing Articles

Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome.

Hu J, Tzeng H, Lee W, Li J, Chuang Y Int J Mol Sci. 2024; 25(15).

PMID: 39125584 PMC: 11312208. DOI: 10.3390/ijms25158015.


Hypoxia impairs urothelial barrier function by inhibiting the expression of tight junction proteins in SV-HUC-1 cells.

Luo H, Zhou H, Chen Y, Sun X, Li Y, Li G J Cell Mol Med. 2024; 28(14):e18545.

PMID: 39031471 PMC: 11258885. DOI: 10.1111/jcmm.18545.


Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions.

Ashraf S, Clarkson T, Malykhina A J Pharmacol Exp Ther. 2024; 390(2):222-232.

PMID: 38565309 PMC: 11264256. DOI: 10.1124/jpet.123.002081.


Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review.

Poletajew S, Brzozka M, Krajewski W, Kamecki H, Nyk L, Kryst P Pain Ther. 2023; 13(1):1-22.

PMID: 37917298 PMC: 10796878. DOI: 10.1007/s40122-023-00559-1.


Cannabidiol as a Promising Therapeutic Option in IC/BPS: In Vitro Evaluation of Its Protective Effects against Inflammation and Oxidative Stress.

Kuret T, Kreft M, Romih R, Veranic P Int J Mol Sci. 2023; 24(5).

PMID: 36902479 PMC: 10003465. DOI: 10.3390/ijms24055055.